All funding news
I

Immuneel Therapeutics

🇮🇳INGene Therapy

Immuneel Therapeutics develops affordable CAR-T cell therapies for blood cancers including lymphoma and leukemia.

Rounds tracked
1

Funding history

I
🇮🇳Immuneel TherapeuticsGene Therapy

Immuneel Therapeutics develops affordable CAR-T cell therapies for blood cancers including lymphoma and leukemia.

$1Series B

Want a deeper look at Immuneel Therapeutics?

Ask Dormy who's likely on their cap table, what kind of companies their lead investor backs, and how to reach them.

Ask in Telegram →